Share |
 

Pharmaceutical Industry Reports

Teva Pharma appoints Jeremy Levin as CEO of Bristol-Myers

User Rating: / 1
Written by Artika Shah   
Teva Pharmaceuticals Industries Ltd Tuesday said it has appointed Jeremy Levin of Bristol-Myers Squibb Co, the news reports said Tuesday. Jeremy will replace Shlomo Yanai as the CEO of the company as the world's biggest generic-drugmaker intends to diversify its portfolio of innovative medicines.
Read more...
 

Is the American Psychiatric Association in Bed with Big Pharma?

User Rating: / 1
Written by Ralph E. Stone   

Medications are widely used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder, anxiety disorders, and attention deficit-hyperactivity disorder. Sometimes medications are used with other treatments such as psychotherapy.
Read more...
 

Scandal Over Mediator, a French Weight-Loss Drug, Prompts Calls for Wide Changes

User Rating: / 1
Written by SCOTT SAYARE   
In 33 years on pharmacy shelves here, the diabetes drug Mediator was prescribed to an estimated five million French patients, many of them diabetics, many others hoping simply to lose weight.
Read more...
 

Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Th

User Rating: / 1
Written by Inovio Pharmaceuticals, Inc.   
The article noted: "Fierce Vaccines spotlights 10 therapeutic vaccines now being tested in humans and generating buzz. Those for cancer get the most attention, in part because their anticipated gentleness stands in such stark contrast to the known toxicities of conventional chemotherapies….
Read more...
 

Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharm

User Rating: / 1
Written by Camfed and Alacrita   
Alacrita, which is changing the face of life science consulting, is delighted to launch its Life Sciences Seasonal Appeal.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 21 - 25 of 68
Please Click Here to submit the latest information about your company and we are here to share it across the Pharmaceutical Industry worldwide.

Subscriber Here